Angiotensin II (Ang II) is considered the major final mediator of the renin-angiotensin system.
The actions of Ang II have been implicated in many cardiovascular conditions, such as …

ical states. This raises the important question of their function in the cardiovascular system
relative to that of AT1. The 2 receptor subtypes also appear to have different signaling …

ABSTRACT A reduction in L‐arginine availability has been implicated in the impairment of
endothelium‐dependent nitric oxide (NO)‐mediated vasodilation by ischemia‐reperfusion …

Abstract Angiotensin II (Ang II) plays important roles in the development of cardiovascular
diseases including hypertension, renal diseases, cardiac hypertrophy, congestive heart …

The active hormone of the renin–angiotensin system (RAS), angiotensin II (Ang II), is
involved in several human diseases, driving the development and clinical use of several …

BACKGROUND: Daunorubicin is an anthracycline anti-tumor agent; anthracycline
chemotherapy in cancer can cause severe cardiomyopathy leading to a frequently fatal …

Cardiovascular disease incidence continues to rise and new treatment paradigms are
warranted. We reported previously that activation of Angiotensin II receptor (encoded by the …

Objective. The focus of the present study is to evaluate the effects of Angiotensin II (Ang II)
on neuronal apoptosis after HIE and the potential underlying mechanisms. Methods. Primary …

BACKGROUND: Cardioprotection with angiotensin II (AngII) type 1 receptor (AT1R)
blockade was associated with AngII type 2 receptor (AT2R) upregulation and activation …

Background: We have previously shown that angiotensin II type 1 receptor blockers induce
cardioprotection and upregulate angiotensin II type 2 receptor during in vivo …